Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama

A clinical research study for the treatment of Alzheimer's Disease

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Xenoscience Inc.
Phoenix Arizona 85013

Clinical trial for Early Alzheimers

View More ▼

UPDATED

Phoenix Arizona 85013

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

UPDATED

Phoenix Arizona 85004

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

UPDATED

Phoenix Arizona 85018

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

UPDATED

Phoenix Arizona 85004

A Phase 2 clinical study for patients with Alzheimer's Disease

UPDATED

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85718

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

UPDATED

Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

UPDATED

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Phoenix Arizona

A clinical research study for the treatment of Alzheimer's Disease

Phoenix Arizona 85005

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

Phoenix Arizona 85004

A clinical trial to evaluate treatments using Bryostatin 1 and Placebo for patients with Alzheimer's Disease, Moderately Severe Alzheimer's Disease

Phoenix Arizona 85006

A clinical trial to evaluate treatments using CAD106 Immunotherapy, Placebo to CAD106, CNP520 and Placebo to CNP520 for patients with Alzheimer's Disease

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Alzheimer's Disease, Traumatic Brain Injury or Depression

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating 18F-AV-1451 for the treatment of Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Tucson Arizona

A clinical research study for the treatment of Alzheimer's Disease

Tucson Arizona 85704

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

Tucson Arizona 85704

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

Tucson Arizona 85718

Patients are needed to participate in a clinical research study of Aducanumab (BIIB037) and Placebo to evaluate Alzheimer's Disease, Early

Arkansas

Fayetteville Arkansas 72703

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Little Rock Arkansas 72211

A clinical research study of Suvorexant 10 mg, Suvorexant 20 mg and Placebo for the treatment of Insomnia or Alzheimer's Disease

Little Rock Arkansas 72211

A Phase 2 clinical study for patients with Moderate Alzheimer's Disease

California

NEW

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

NEW

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

NEW

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease